Peptides for Shetland Sheepdog skin and coat
The short answer
Shetland Sheepdogs carry an elevated predisposition to skin and coat. The compounds investigated for it are GHK-Cu. At a typical Shetland Sheepdog weight of 6–12 kg (13–26 lb), this breed falls in the small / toy breed dosing class. Critically, this breed carries a genetic trait that changes what is safe: MDR1 (ABCB1) mutation risk — genetic testing required before ivermectin
The Shetland Sheepdog-specific risk
⚠ MDR1 (ABCB1) mutation risk — genetic testing required before ivermectin
This breed carries a meaningful frequency of the MDR1 gene mutation, which prevents the drug-efflux protein at the blood-brain barrier from clearing ivermectin out of the central nervous system. Affected dogs develop neurotoxicity at doses other dogs tolerate without difficulty, and at the investigational oncology doses discussed on this site that reaction can be fatal. A cheek-swab test through Washington State University or a commercial laboratory settles the question and must be done before the first dose.
Skin and coat in Shetland Sheepdogs
Coat quality is often the first visible sign of an underlying problem — endocrine disease, allergy, parasites, or nutritional deficiency — so the first step is always establishing why rather than treating the appearance. Where a specific dermatologic problem is being managed, GHK-Cu is the compound with the most relevant research, largely from human dermatology, and the topical route is both the best studied and the lowest risk since systemic copper exposure is minimal.
Dosing at Shetland Sheepdog body weight
Calculated for a 9 kg (20 lb) dog — the midpoint of the typical range for this breed.
| Compound | Dose at 9 kg | Frequency | Evidence |
|---|---|---|---|
| GHK-Cu | 0.5-1 mg per day injectable, or topical twice daily | Daily (injectable) / twice daily (topical) | Emerging evidence |
Weigh your dog rather than using a breed average — an individual Shetland Sheepdog can sit well outside the typical range. Use the dose calculator for an exact figure.
Common questions
What peptides are used for skin and coat in Shetland Sheepdogs?+
GHK-Cu are investigated for skin and coat. Note that Shetland Sheepdogs carry a specific genetic consideration: MDR1 (ABCB1) mutation risk — genetic testing required before ivermectin
How much should a Shetland Sheepdog be given?+
Shetland Sheepdogs typically weigh 6–12 kg (13–26 lb), placing them in the small / toy breed class. . Weigh your dog rather than relying on a breed average.
Are Shetland Sheepdogs more prone to skin and coat?+
Yes. Shetland Sheepdogs carry an elevated predisposition to skin and coat. Coat quality, hair regrowth, and chronic dermatologic conditions.
References
- 1.Canapp SO Jr, Farese JP, Schultz GS, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Veterinary Surgery, 2003. PMID 14648529
- 2.Maquart FX, Bellon G, Chaqour B, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. Journal of Clinical Investigation, 1993. PMID 8227353
- 3.Pickart L, Vasquez-Soltero JM, Margolina A GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International, 2015. PMID 26236730
- 4.Pickart L, Margolina A Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 2018. PMID 29986520
Other conditions Shetland Sheepdogs are predisposed to: Osteoarthritis.
Where to source research peptides
Compound quality is the variable most owners underestimate. Purity, accurate peptide content, and correct labelling determine whether any published dosing figure means anything at all. Pet & Peps Research publishes third-party testing on the compounds covered in this guide and supports this site.
Educational information — not veterinary medical advice
Everything on this page is compiled from published peer-reviewed literature for educational and research purposes. It does not establish a veterinarian-client-patient relationship (VCPR) and is not a substitute for veterinary examination and diagnosis. Most compounds described here are investigational or used off-label and are not FDA-approved for these purposes in dogs. Extralabel drug use in animals requires a valid VCPR and the direct supervision of a licensed veterinarian under AMDUCA (21 U.S.C. §360b). Dosing figures are reported as they appear in the source literature and are not recommendations.